Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 41 entries
Sorted by: Best Match Show Resources per page
IS IT WORTH PURSUING GRADUATE STUDIES? IS A STEM ORIENTATION THE BEST OPTION?

STEM and men

Manea D, Otoiu A, Țițan E.
GSID: BE8KtSfwNb0J
A Otoiu, E Țițan, P Dorel, D Manea - INTED2021 Proceedings, 2021 - library.iated.org

A question often asked by many prospective students is whether it pays to pursue an advanced (Master's, Professional, or Ph. D.) degree. In some cases, there is mixed evidence that getting an advanced degree may lead to earnings improvements...

Cite
Otoiu, A., Țițan, E., Dorel, P., & Manea, D. (2021). IS IT WORTH PURSUING GRADUATE STUDIES? IS A STEM ORIENTATION THE BEST OPTION?. In INTED2021 Proceedings (pp. 570-580). IATED.
Otoiu, A., et al. "IS IT WORTH PURSUING GRADUATE STUDIES? IS A STEM ORIENTATION THE BEST OPTION?." INTED2021 Proceedings. IATED, 2021.
Copy Download .nbib Format: MLA
Tilt-compensating algorithm for phase-shift interferometry.

Applied optics

Dobroiu A, Apostol D, Nascov V, Damian V.
PMID: 12009153
Appl Opt. 2002 May 01;41(13):2435-9. doi: 10.1364/ao.41.002435.

A self-calibrating algorithm for phase-shift interferometry is described that is able to cancel the effect of accidental relative tilts that may occur during phase stepping. The algorithm is able to retrieve both the phase steps and the tilts that...

Cite
Dobroiu A, Apostol D, Nascov V, et al. Tilt-compensating algorithm for phase-shift interferometry. Appl Opt. 2002;41(13):2435-9doi: 10.1364/ao.41.002435.
Dobroiu, A., Apostol, D., Nascov, V., & Damian, V. (2002). Tilt-compensating algorithm for phase-shift interferometry. Applied optics, 41(13), 2435-9. https://doi.org/10.1364/ao.41.002435
Dobroiu, Adrian, et al. "Tilt-compensating algorithm for phase-shift interferometry." Applied optics vol. 41,13 (2002): 2435-9. doi: https://doi.org/10.1364/ao.41.002435
Dobroiu A, Apostol D, Nascov V, Damian V. Tilt-compensating algorithm for phase-shift interferometry. Appl Opt. 2002 May 01;41(13):2435-9. doi: 10.1364/ao.41.002435. PMID: 12009153.
Copy Download .nbib Format: NLM
Predictors of skin self-examination before and after a melanoma diagnosis: the role of medical advice and patient's level of education.

International archives of medicine

Körner A, Coroiu A, Martins C, Wang B.
PMID: 23446040
Int Arch Med. 2013 Feb 27;6(1):8. doi: 10.1186/1755-7682-6-8.

BACKGROUND: Cutaneous melanoma is the fastest growing tumor of the skin and the median life span of patients with advanced disease is less than a year. Melanoma-related mortality can be reduced through early detection via clinical skin exams and...

Cite
Körner A, Coroiu A, Martins C, et al. Predictors of skin self-examination before and after a melanoma diagnosis: the role of medical advice and patient's level of education. Int Arch Med. 2013;6(1):8doi: 10.1186/1755-7682-6-8.
Körner, A., Coroiu, A., Martins, C., & Wang, B. (2013). Predictors of skin self-examination before and after a melanoma diagnosis: the role of medical advice and patient's level of education. International archives of medicine, 6(1), 8. https://doi.org/10.1186/1755-7682-6-8
Körner, Annett, et al. "Predictors of skin self-examination before and after a melanoma diagnosis: the role of medical advice and patient's level of education." International archives of medicine vol. 6,1 (2013): 8. doi: https://doi.org/10.1186/1755-7682-6-8
Körner A, Coroiu A, Martins C, Wang B. Predictors of skin self-examination before and after a melanoma diagnosis: the role of medical advice and patient's level of education. Int Arch Med. 2013 Feb 27;6(1):8. doi: 10.1186/1755-7682-6-8. PMID: 23446040; PMCID: PMC3599942.
Copy Download .nbib Format: NLM
Hepatitis B and C in hematopoietic stem cell transplant.

Mediterranean journal of hematology and infectious diseases

Locasciulli A, Montante B, Morelli E, Gulino V, Proia A, Pinazzi MB.
PMID: 21415955
Mediterr J Hematol Infect Dis. 2009 Dec 03;1(3):e2009016. doi: 10.4084/MJHID.2009.016.

Although the risk of acquisition of hepatitis B or hepatitis C virus through blood products has considerably reduced since the last decade, some infected patients are candidates to stem cell transplantation. Others may have no alternative than an infected...

Cite
Locasciulli A, Montante B, Morelli E, et al. Hepatitis B and C in hematopoietic stem cell transplant. Mediterr J Hematol Infect Dis. 2009;1(3):e2009016doi: 10.4084/MJHID.2009.016.
Locasciulli, A., Montante, B., Morelli, E., Gulino, V., Proia, A., & Pinazzi, M. B. (2009). Hepatitis B and C in hematopoietic stem cell transplant. Mediterranean journal of hematology and infectious diseases, 1(3), e2009016. https://doi.org/10.4084/MJHID.2009.016
Locasciulli, Anna, et al. "Hepatitis B and C in hematopoietic stem cell transplant." Mediterranean journal of hematology and infectious diseases vol. 1,3 (2009): e2009016. doi: https://doi.org/10.4084/MJHID.2009.016
Locasciulli A, Montante B, Morelli E, Gulino V, Proia A, Pinazzi MB. Hepatitis B and C in hematopoietic stem cell transplant. Mediterr J Hematol Infect Dis. 2009 Dec 03;1(3):e2009016. doi: 10.4084/MJHID.2009.016. PMID: 21415955; PMCID: PMC3033124.
Copy Download .nbib Format: NLM
Molecular basis of the anti-hyperglycemic activity of RA-3 in hyperlipidemic and streptozotocin-induced type 2 diabetes in rats.

Diabetology & metabolic syndrome

Mabhida SE, Johnson R, Ndlovu M, Louw J, Opoku A, Mosa RA.
PMID: 30976328
Diabetol Metab Syndr. 2019 Mar 29;11:27. doi: 10.1186/s13098-019-0424-z. eCollection 2019.

BACKGROUND: Insulin resistance is a hallmark of type 2 diabetes mellitus (T2DM) and the underlying cause of various metabolic changes observed in type 2 diabetic patients. This study investigated the molecular basis of the anti-hyperglycemic activity of the lanosteryl...

Cite
Mabhida SE, Johnson R, Ndlovu M, et al. Molecular basis of the anti-hyperglycemic activity of RA-3 in hyperlipidemic and streptozotocin-induced type 2 diabetes in rats. Diabetol Metab Syndr. 2019;11:27doi: 10.1186/s13098-019-0424-z.
Mabhida, S. E., Johnson, R., Ndlovu, M., Louw, J., Opoku, A., & Mosa, R. A. (2019). Molecular basis of the anti-hyperglycemic activity of RA-3 in hyperlipidemic and streptozotocin-induced type 2 diabetes in rats. Diabetology & metabolic syndrome, 1127. https://doi.org/10.1186/s13098-019-0424-z
Mabhida, Sihle Ephraim, et al. "Molecular basis of the anti-hyperglycemic activity of RA-3 in hyperlipidemic and streptozotocin-induced type 2 diabetes in rats." Diabetology & metabolic syndrome vol. 11 (2019): 27. doi: https://doi.org/10.1186/s13098-019-0424-z
Mabhida SE, Johnson R, Ndlovu M, Louw J, Opoku A, Mosa RA. Molecular basis of the anti-hyperglycemic activity of RA-3 in hyperlipidemic and streptozotocin-induced type 2 diabetes in rats. Diabetol Metab Syndr. 2019 Mar 29;11:27. doi: 10.1186/s13098-019-0424-z. eCollection 2019. PMID: 30976328; PMCID: PMC6440151.
Copy Download .nbib Format: NLM
Challenges in the Surgical Treatment of Atrioventricular Septal Defect in Children With and Without Down Syndrome in Romania-A Developing Country.

Frontiers in pediatrics

Olariu IC, Popoiu A, Ardelean AM, Isac R, Steflea RM, Olariu T, Chirita-Emandi A, Stroescu R, Gafencu M, Doros G.
PMID: 34307243
Front Pediatr. 2021 Jul 07;9:612644. doi: 10.3389/fped.2021.612644. eCollection 2021.

No abstract available.

Cite
Olariu IC, Popoiu A, Ardelean AM, et al. Challenges in the Surgical Treatment of Atrioventricular Septal Defect in Children With and Without Down Syndrome in Romania-A Developing Country. Front Pediatr. 2021;9:612644doi: 10.3389/fped.2021.612644.
Olariu, I. C., Popoiu, A., Ardelean, A. M., Isac, R., Steflea, R. M., Olariu, T., Chirita-Emandi, A., Stroescu, R., Gafencu, M., & Doros, G. (2021). Challenges in the Surgical Treatment of Atrioventricular Septal Defect in Children With and Without Down Syndrome in Romania-A Developing Country. Frontiers in pediatrics, 9612644. https://doi.org/10.3389/fped.2021.612644
Olariu, Ioana-Cristina, et al. "Challenges in the Surgical Treatment of Atrioventricular Septal Defect in Children With and Without Down Syndrome in Romania-A Developing Country." Frontiers in pediatrics vol. 9 (2021): 612644. doi: https://doi.org/10.3389/fped.2021.612644
Olariu IC, Popoiu A, Ardelean AM, Isac R, Steflea RM, Olariu T, Chirita-Emandi A, Stroescu R, Gafencu M, Doros G. Challenges in the Surgical Treatment of Atrioventricular Septal Defect in Children With and Without Down Syndrome in Romania-A Developing Country. Front Pediatr. 2021 Jul 07;9:612644. doi: 10.3389/fped.2021.612644. eCollection 2021. PMID: 34307243; PMCID: PMC8292620.
Copy Download .nbib Format: NLM
The Solidification/Stabilization of Wastewater (From a Landfill Leachate) in Specially Designed Binders Based on Coal Ash.

Materials (Basel, Switzerland)

Oproiu CL, Voicu G, Bădănoiu A, Nicoară AI.
PMID: 34640021
Materials (Basel). 2021 Sep 27;14(19). doi: 10.3390/ma14195610.

The aim of this study is to assess the possibility to solidify/stabilize a liquid waste from a municipal waste landfill using binders based on coal ash (fly ash and bottom ash) and specially designed cements for waste treatment (INERCEM)....

Cite
Oproiu CL, Voicu G, Bădănoiu A, et al. The Solidification/Stabilization of Wastewater (From a Landfill Leachate) in Specially Designed Binders Based on Coal Ash. Materials (Basel). 2021;14(19)doi: 10.3390/ma14195610.
Oproiu, C. L., Voicu, G., Bădănoiu, A., & Nicoară, A. I. (2021). The Solidification/Stabilization of Wastewater (From a Landfill Leachate) in Specially Designed Binders Based on Coal Ash. Materials (Basel, Switzerland), 14(19), . https://doi.org/10.3390/ma14195610
Oproiu, Carmen-Lidia, et al. "The Solidification/Stabilization of Wastewater (From a Landfill Leachate) in Specially Designed Binders Based on Coal Ash." Materials (Basel, Switzerland) vol. 14,19 (2021). doi: https://doi.org/10.3390/ma14195610
Oproiu CL, Voicu G, Bădănoiu A, Nicoară AI. The Solidification/Stabilization of Wastewater (From a Landfill Leachate) in Specially Designed Binders Based on Coal Ash. Materials (Basel). 2021 Sep 27;14(19). doi: 10.3390/ma14195610. PMID: 34640021; PMCID: PMC8510009.
Copy Download .nbib Format: NLM
Neuroendocrine neoplasia and bone (Review).

Experimental and therapeutic medicine

Ghemigian A, Carsote M, Sandru F, Petca RC, Oproiu AM, Petca A, Valea A.
PMID: 34584564
Exp Ther Med. 2021 Nov;22(5):1219. doi: 10.3892/etm.2021.10653. Epub 2021 Aug 26.

This is a narrative review focusing on neuroendocrine neoplasia (NEN) and bone status, in terms of metastases and osteoporosis/fractures. One fifth of NEN have skeletal dissemination, this affinity being regulated by intrinsic tumor factors such as the C-X-C chemokine...

Cite
Ghemigian A, Carsote M, Sandru F, et al. Neuroendocrine neoplasia and bone (Review). Exp Ther Med. 2021;22(5):1219doi: 10.3892/etm.2021.10653.
Ghemigian, A., Carsote, M., Sandru, F., Petca, R. C., Oproiu, A. M., Petca, A., & Valea, A. (2021). Neuroendocrine neoplasia and bone (Review). Experimental and therapeutic medicine, 22(5), 1219. https://doi.org/10.3892/etm.2021.10653
Ghemigian, Adina, et al. "Neuroendocrine neoplasia and bone (Review)." Experimental and therapeutic medicine vol. 22,5 (2021): 1219. doi: https://doi.org/10.3892/etm.2021.10653
Ghemigian A, Carsote M, Sandru F, Petca RC, Oproiu AM, Petca A, Valea A. Neuroendocrine neoplasia and bone (Review). Exp Ther Med. 2021 Nov;22(5):1219. doi: 10.3892/etm.2021.10653. Epub 2021 Aug 26. PMID: 34584564; PMCID: PMC8422397.
Copy Download .nbib Format: NLM
Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.

Transplantation and cellular therapy

Sahebi F, Eikema DJ, Koster L, Kroger N, Meijer E, van Doesum JA, Rovira M, Koc Y, Angelucci E, Blaise D, Sammassimo S, McDonald A, Arroyo CH, Sanchez JF, Forcade E, Castagna L, Stölzel F, Sanz J, Tischer J, Ciceri F, Valcarcel D, Proia A, Hayden PJ, Beksac M, Yakoub-Agha I, Schönland S.
PMID: 34543768
Transplant Cell Ther. 2021 Sep 17; doi: 10.1016/j.jtct.2021.09.008. Epub 2021 Sep 17.

Graft-versus-host disease (GVHD) remains among the major causes of treatment failure in patients with multiple myeloma (MM) undergoing allogeneic hematopoietic cell transplantation (allo-HCT). The use of post-transplantation cyclophosphamide (PT-Cy) is now a well-established and widely used method for GVHD...

Cite
Sahebi F, Eikema DJ, Koster L, et al. Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Transplant Cell Ther. 2021;doi: 10.1016/j.jtct.2021.09.008.
Sahebi, F., Eikema, D. J., Koster, L., Kroger, N., Meijer, E., van Doesum, J. A., Rovira, M., Koc, Y., Angelucci, E., Blaise, D., Sammassimo, S., McDonald, A., Arroyo, C. H., Sanchez, J. F., Forcade, E., Castagna, L., Stölzel, F., Sanz, J., Tischer, J., Ciceri, F., Valcarcel, D., Proia, A., Hayden, P. J., Beksac, M., Yakoub-Agha, I., & Schönland, S. (2021). Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Transplantation and cellular therapy, . https://doi.org/10.1016/j.jtct.2021.09.008
Sahebi, Firoozeh, et al. "Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation." Transplantation and cellular therapy vol. (2021). doi: https://doi.org/10.1016/j.jtct.2021.09.008
Sahebi F, Eikema DJ, Koster L, Kroger N, Meijer E, van Doesum JA, Rovira M, Koc Y, Angelucci E, Blaise D, Sammassimo S, McDonald A, Arroyo CH, Sanchez JF, Forcade E, Castagna L, Stölzel F, Sanz J, Tischer J, Ciceri F, Valcarcel D, Proia A, Hayden PJ, Beksac M, Yakoub-Agha I, Schönland S. Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Transplant Cell Ther. 2021 Sep 17; doi: 10.1016/j.jtct.2021.09.008. Epub 2021 Sep 17. PMID: 34543768.
Copy Download .nbib Format: NLM
Ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesity.

Obesity science & practice

Cuatrecasas G, de Cabo F, Coves MJ, Patrascioiu I, Aguilar G, March S, Balfegó M, Bretxa C, Calbo M, Cuatrecasas G, Aranda G, Orois A, Bové I, Munoz-Marron E, García-Lorda P.
PMID: 33354344
Obes Sci Pract. 2020 Oct 08;6(6):660-667. doi: 10.1002/osp4.453. eCollection 2020 Dec.

CONCLUSIONS: US is a valid method to measure all different abdominal fat depots.

Cite
Cuatrecasas G, de Cabo F, Coves MJ, et al. Ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesity. Obes Sci Pract. 2020;6(6):660-667doi: 10.1002/osp4.453.
Cuatrecasas, G., de Cabo, F., Coves, M. J., Patrascioiu, I., Aguilar, G., March, S., Balfegó, M., Bretxa, C., Calbo, M., Cuatrecasas, G., Aranda, G., Orois, A., Bové, I., Munoz-Marron, E., & García-Lorda, P. (2020). Ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesity. Obesity science & practice, 6(6), 660-667. https://doi.org/10.1002/osp4.453
Cuatrecasas, Guillem, et al. "Ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesity." Obesity science & practice vol. 6,6 (2020): 660-667. doi: https://doi.org/10.1002/osp4.453
Cuatrecasas G, de Cabo F, Coves MJ, Patrascioiu I, Aguilar G, March S, Balfegó M, Bretxa C, Calbo M, Cuatrecasas G, Aranda G, Orois A, Bové I, Munoz-Marron E, García-Lorda P. Ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesity. Obes Sci Pract. 2020 Oct 08;6(6):660-667. doi: 10.1002/osp4.453. eCollection 2020 Dec. PMID: 33354344; PMCID: PMC7746969.
Copy Download .nbib Format: NLM
Primary hyperparathyroidism-related giant parathyroid adenoma (Review).

Experimental and therapeutic medicine

Ghemigian A, Trandafir AI, Petrova E, Carsote M, Valea A, Filipescu A, Oproiu AM, Sandru F.
PMID: 34934453
Exp Ther Med. 2022 Jan;23(1):88. doi: 10.3892/etm.2021.11011. Epub 2021 Nov 26.

Primary hyperparathyroidism (PHPT), an endocrine condition caused by a parathyroid adenoma (PTA) in 80-85% of the cases, has shifted in the modern era to a mildly symptomatic phenotype due to the prompt recognition of hypercalcemia and to a minimally...

Cite
Ghemigian A, Trandafir AI, Petrova E, et al. Primary hyperparathyroidism-related giant parathyroid adenoma (Review). Exp Ther Med. 2021;23(1):88doi: 10.3892/etm.2021.11011.
Ghemigian, A., Trandafir, A. I., Petrova, E., Carsote, M., Valea, A., Filipescu, A., Oproiu, A. M., & Sandru, F. (2022). Primary hyperparathyroidism-related giant parathyroid adenoma (Review). Experimental and therapeutic medicine, 23(1), 88. https://doi.org/10.3892/etm.2021.11011
Ghemigian, Adina, et al. "Primary hyperparathyroidism-related giant parathyroid adenoma (Review)." Experimental and therapeutic medicine vol. 23,1 (2022): 88. doi: https://doi.org/10.3892/etm.2021.11011
Ghemigian A, Trandafir AI, Petrova E, Carsote M, Valea A, Filipescu A, Oproiu AM, Sandru F. Primary hyperparathyroidism-related giant parathyroid adenoma (Review). Exp Ther Med. 2022 Jan;23(1):88. doi: 10.3892/etm.2021.11011. Epub 2021 Nov 26. PMID: 34934453; PMCID: PMC8652388.
Copy Download .nbib Format: NLM
Evaluation of a Methylcellulose and Hyaluronic Acid Hydrogel as a Vehicle for Rectal Delivery of Biologics.

Pharmaceutics

Aprodu A, Mantaj J, Raimi-Abraham B, Vllasaliu D.
PMID: 30893796
Pharmaceutics. 2019 Mar 19;11(3). doi: 10.3390/pharmaceutics11030127.

Biologics have changed the management of Inflammatory Bowel Disease (IBD), but there are concerns regarding unexpected systemic toxicity and loss of therapeutic response following administration by injection. Local delivery of biologics directly to the inflamed mucosa via rectal enema...

Cite
Aprodu A, Mantaj J, Raimi-Abraham B, et al. Evaluation of a Methylcellulose and Hyaluronic Acid Hydrogel as a Vehicle for Rectal Delivery of Biologics. Pharmaceutics. 2019;11(3)doi: 10.3390/pharmaceutics11030127.
Aprodu, A., Mantaj, J., Raimi-Abraham, B., & Vllasaliu, D. (2019). Evaluation of a Methylcellulose and Hyaluronic Acid Hydrogel as a Vehicle for Rectal Delivery of Biologics. Pharmaceutics, 11(3), . https://doi.org/10.3390/pharmaceutics11030127
Aprodu, Andreea, et al. "Evaluation of a Methylcellulose and Hyaluronic Acid Hydrogel as a Vehicle for Rectal Delivery of Biologics." Pharmaceutics vol. 11,3 (2019). doi: https://doi.org/10.3390/pharmaceutics11030127
Aprodu A, Mantaj J, Raimi-Abraham B, Vllasaliu D. Evaluation of a Methylcellulose and Hyaluronic Acid Hydrogel as a Vehicle for Rectal Delivery of Biologics. Pharmaceutics. 2019 Mar 19;11(3). doi: 10.3390/pharmaceutics11030127. PMID: 30893796; PMCID: PMC6471061.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 41 entries